Shares of ValiRx plc (LON:VAL – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 0.31 and traded as low as GBX 0.19. ValiRx shares last traded at GBX 0.20, with a volume of 74,967,289 shares.
ValiRx Price Performance
The company has a current ratio of 9.66, a quick ratio of 1.27 and a debt-to-equity ratio of 0.19. The firm has a market cap of £1.46 million, a PE ratio of -0.21 and a beta of 0.59. The stock has a 50 day simple moving average of GBX 0.28 and a 200-day simple moving average of GBX 0.31.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
